Gout & Crystal Arthritis: Diagnosis, Treatment and Care
A sudden red swollen joint can involve gout, CPPD or infection. Understand why assessment comes first and why flare relief differs from preventing future crystal-related disease.
Quick verdict
Get a newly hot swollen joint assessed promptly. Once gout is diagnosed, ask for both a flare plan and a long-term urate plan when indicated. CPPD has a separate management pathway; no “joint detox” replaces it.
Educational adult information. For new, severe or concerning symptoms, seek appropriate clinical assessment. Follow individual care instructions rather than using this page to change treatment.
On this page
- Quick verdict
- Gout, CPPD and infection are not interchangeable
- Which tests clarify suspected gout?
- Flare care and long-term treatment have different purposes
- Treat-to-target follow-up is more than “take a tablet”
- Diet matters, but a cure diet is not established
- CPPD requires a separate discussion
- A useful follow-up conversation
- Frequently asked questions
- Continue your research
- Sources, research method and limitations
Gout, CPPD and infection are not interchangeable
Gout involves urate crystals; CPPD involves calcium pyrophosphate crystals. Infection can produce a similar painful swollen-joint presentation, so appearance alone is not a diagnosis. Septic arthritis generally needs hospital treatment, antibiotics and sometimes drainage; waiting for a supplement or diet change can be harmful. NHS Wales: Septic arthritis.
Record how rapidly symptoms developed, which joint is affected, fever/illness, recent injury/procedure, previous episodes and current medicines. Report an artificial joint or immune-suppressing treatment. These details help triage rather than rule infection out.
Which tests clarify suspected gout?
A clinician uses history and examination with appropriate tests. NICE advises repeating urate at least two weeks after a flare settles when it is below 6 mg/dL during the flare but gout is strongly suspected. An uncertain diagnosis may require joint-fluid microscopy or selected imaging. NICE NG219.
A blood number should be interpreted in context; ask whether further assessment is needed if symptoms persist. Bring previous results, not just a statement that they were “normal.” NIAMS gout assessment.
Flare care and long-term treatment have different purposes
| Care track | Purpose | What to ask |
|---|---|---|
| Acute flare treatment | Relieve pain and inflammation. | Which option fits my kidney, stomach, heart and medicine history? |
| Urate-lowering treatment | Reduce urate crystal burden and prevent future disease when indicated. | What is my target, monitoring plan and reason for this treatment? |
| Prevention during treatment initiation | Limit flares that can occur while urate therapy is started/titrated. | What prevention and follow-up have been prescribed? |
ACR 2020 supports allopurinol as preferred first-line urate-lowering therapy, including selected people with CKD, a target below 6 mg/dL and anti-inflammatory prevention for at least three to six months during initiation. Drug choice and dose remain individual decisions. ACR gout guideline (2020).
Treat-to-target follow-up is more than “take a tablet”
NICE uses serial urate measurements to guide treatment toward below 6 mg/dL (360 micromol/L), with a lower target sometimes considered for tophi, chronic gouty arthritis or continuing frequent flares. Once target is reached, ongoing treatment and monitoring still matter. NICE long-term gout care.
Write down the target, latest result, next check, flare contact plan and any adverse effects. Urate-lowering medicine may be needed even when no joint currently hurts; do not stop it because an episode has passed. NHS: Gout.
Ask about kidney function, cardiovascular disease, interactions and prior drug reactions. ACR recommends selected ancestry-related HLA-B*5801 testing before allopurinol, not indiscriminate testing of every person. The clinician should decide its relevance; this guide does not assign ancestry or genetic risk to you. ACR gout guideline: medication and genetic-testing recommendations (2020).
Diet matters, but a cure diet is not established
NIAMS recommends addressing alcohol, sugar-sweetened drinks and relevant high-purine food choices while supporting a balanced eating pattern. It emphasizes that lifestyle alone is insufficient for frequent-flare or tophaceous gout. NIAMS: Gout diagnosis, treatment and daily care.
NICE finds insufficient evidence that a specific diet alone prevents flares or lowers urate. Genetics, medicines and other illness also matter; blame is not a treatment plan. NICE diet recommendations.
An original practical review can choose one feasible change, such as replacing a usual sugary drink, while retaining adequate food and following prescribed care. Ask for individual advice before forced fluid intake if heart/kidney care restricts fluids. Avoid crash diets or purchases marketed as dissolving all joint crystals.
CPPD requires a separate discussion
CPPD often affects older adults and commonly the knee, but other joints can be involved. Joint-fluid analysis and imaging may help confirm it. Some metabolic or inherited conditions can be associated, making additional testing relevant in selected cases.
There is no established treatment to dissolve CPP crystals. Care focuses on inflammation relief and, sometimes, prevention of recurrent attacks; a clinician may consider aspiration, suitable anti-inflammatory medicines or a joint injection. Gout urate targets do not describe CPPD treatment. ACR: Calcium pyrophosphate deposition (updated February 2025).
Ask whether the episode is truly CPPD, whether another cause has been assessed, and how rehabilitation or daily tasks should be adapted when the flare settles.
A useful follow-up conversation
Bring an episode timeline, photographs if available, medicines, test results and the daily task most affected. Ask: “What is the diagnosis? What should I do for the next episode? Is prevention indicated? When do we recheck the treatment goal?”
For a known flare, follow the individual written plan. A new pattern, significant illness or failure to improve needs reassessment rather than repeated self-labeling. The assessment guide and medicine guide help organize those questions.
Frequently asked questions
Can gout occur outside the big toe?
Yes. Location alone cannot confirm or exclude gout, and a painful swollen joint can have other causes.
Does a normal urate during a flare settle the question?
No. A clinician may repeat it after the episode and use other assessment when necessary.
Are CPPD and gout treated identically?
No. Their crystals and long-term treatment aims differ; CPPD does not use the gout urate-lowering target as a crystal-dissolving strategy.
Can I stop urate-lowering treatment when pain disappears?
Do not stop prescribed treatment independently. Its long-term purpose is different from pain relief during a flare.
Sources, research method and limitations
Editorial synthesis by Biraj Health Care; sources checked October 9, 2026. The main guide explains the research method and limitations. Sources include official guidance, systematic reviews and human trials where relevant; access ranged from full retrieved sections to primary abstracts or indexed recommendations. This is not an exhaustive systematic review or independently medically reviewed article. Examples support planning, not diagnosis or individual prescribing.
Policies: Methodology · Sources Policy.